Unable to display view head.php file not found.
 
American Journal of Medicine
 

Eikelboom - Evidence from the Randomized Trials - Figure 15
RE-MEDY: VTE or Related Death

As was the case in RE-COVER I. the result for the primary outcome of RE-MEDY for the initial treatment of acute VTE was statistically similar in patients treated with dabigatran and those treated with warfarin, although the event curves (Figure 15)[9] appear to show a slight trend toward better efficacy with warfarin.  Eikelboom J. Am J Med 2013; published on-line at http://education.amjmed.com/00000. 

References

[9] Schulman S, Kearon C, Kakkar AK, et al; for the RE-MEDY and the RE-SONATE Trials Investigators. Extended use of dabigatran, warfarin, or placebo in venous thromboembolism. N Engl J Med. 2013;368:709-718.

Unable to display view foot.php file not found.